# MIIP

## Overview
The MIIP gene encodes the migration and invasion inhibitory protein, a crucial regulator of cellular dynamics, particularly in the context of cancer biology. This protein is categorized as a tumor suppressor due to its role in inhibiting cell migration and invasion, processes that are often dysregulated in cancerous cells. MIIP exerts its effects by interacting with various cellular components, including cytoskeletal elements and signaling molecules, to maintain cellular architecture and function (Song2010Definition). It is active in both the cytoplasm and nucleus, where it influences critical processes such as cell cycle progression and apoptosis (Song2010Definition). The gene's polymorphisms, such as the rs2295283 variant, further underscore its significance in modulating tumorigenic potential (Song2010Definition). Through its interactions with oncogenic pathways and proteins, MIIP serves as a protective factor against cancer development, making it a potential target for therapeutic interventions (Yan2019MIIP; Gao2022MIIP).

## Structure


## Function
The MIIP gene encodes the migration and invasion inhibitory protein, which plays a significant role in regulating cell migration and invasion, processes crucial for maintaining normal cellular architecture and function. MIIP interacts with cytoskeletal components to inhibit cell motility and invasion, thereby contributing to tumor suppression (Song2010Definition). This protein is active in both the cytoplasm and nucleus, where it influences cell cycle progression and apoptosis, essential processes for cellular homeostasis (Song2010Definition).

In healthy human cells, MIIP is involved in modulating the effects of insulin-like growth factor-binding protein-2 (IGFBP-2), an oncogene product that enhances cell migration and invasion. By binding to IGFBP-2, MIIP blocks its oncogenic functions, thus playing a protective role against cancer development (Song2010Definition). The gene has several single nucleotide polymorphisms (SNPs), with one specific SNP, rs2295283, resulting in a K to E amino acid change at codon 167. This variant, known as 167E, is a more potent inhibitor of colony formation, suggesting its enhanced tumor-suppressive activity (Song2010Definition). These molecular activities underscore MIIP's critical function in maintaining cellular integrity and preventing tumorigenesis.

## Clinical Significance
MIIP (Migration and Invasion Inhibitory Protein) plays a significant role in various cancers, often acting as a tumor suppressor. In gastric cancer, MIIP is downregulated, and its forced expression inhibits cell proliferation, migration, and invasion, suggesting its potential as a therapeutic target. Higher MIIP expression is associated with better survival outcomes in gastric cancer patients (Sun2018MIIP). In endometrial cancer, MIIP expression is significantly decreased, correlating with advanced stages and lymph node metastasis. It inhibits cancer cell migration by blocking the Rac1 signaling pathway, indicating its role in suppressing metastasis (Wang2016MIIP).

In triple-negative breast cancer, MIIP is a favorable prognostic indicator, inhibiting tumor angiogenesis and metastasis by interacting with ITGB3 and reducing β-catenin levels (Gao2022MIIP). In hepatocellular carcinoma, low MIIP expression is linked to higher rates of distant metastasis and poor prognosis, with MIIP potentially inhibiting cancer progression by modulating AKT expression (fang2020miip). These findings highlight MIIP's clinical significance as a potential biomarker and therapeutic target in various cancers.

## Interactions
MIIP (migration and invasion inhibitory protein) is known to interact with several proteins, playing a significant role in various cellular processes. In prostate cancer, MIIP interacts with protein phosphatase 1 alpha (PP1α), facilitating the dephosphorylation of AKT, which leads to the attenuation of the AKT-mTOR signaling pathway. This interaction is crucial for MIIP's tumor-suppressive function, as it inhibits prostate cancer cell proliferation and growth (Yan2019MIIP).

In triple-negative breast cancer (TNBC), MIIP interacts with integrin beta 3 (ITGB3) through an RGD motif, promoting ITGB3 degradation and inhibiting downstream signaling pathways, including the FAK/AKT/β-catenin pathway. This interaction reduces β-catenin levels and suppresses tumor angiogenesis and metastasis (Gao2022MIIP).

In colorectal cancer, MIIP is phosphorylated by PKCε at serine 303, which is essential for its interaction with RelA, a subunit of NF-κB. This interaction prevents the deacetylation of RelA, enhancing its transcriptional activity and promoting tumor metastasis. MIIP also forms a complex with HDAC6, influencing histone acetylation and gene expression related to cancer cell invasion (Chen2017PKCε).


## References


1. (fang2020miip) J Fang, Y-L Chen, H-B Yao, S-S Peng, P Yang, and Z-Y Ding. Miip inhibits malignant progression of hepatocellular carcinoma through regulating akt. European Review for Medical & Pharmacological Sciences, 2020. This article has 6 citations.

[2. (Sun2018MIIP) Dan Sun, Yiwei Wang, Shanshan Jiang, Gang Wang, and Yan Xin. Miip is downregulated in gastric cancer and its forced expression inhibits proliferation and invasion of gastric cancer cells in vitro and in vivo. OncoTargets and Therapy, Volume 11:8951–8964, December 2018. URL: http://dx.doi.org/10.2147/OTT.S173393, doi:10.2147/ott.s173393. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.2147/OTT.S173393)

[3. (Gao2022MIIP) Yujing Gao, Yujie Fang, Yongli Huang, Rui Ma, Xixi Chen, Fang Wang, Xiuying Pei, Yuanqi Gao, Xuehua Chen, Xinrui Liu, Jingxuan Shan, and Pu Li. Miip functions as a novel ligand for itgb3 to inhibit angiogenesis and tumorigenesis of triple-negative breast cancer. Cell Death &amp; Disease, September 2022. URL: http://dx.doi.org/10.1038/s41419-022-05255-0, doi:10.1038/s41419-022-05255-0. This article has 6 citations.](https://doi.org/10.1038/s41419-022-05255-0)

[4. (Song2010Definition) Fangfang Song, Ping Ji, Hong Zheng, Fengju Song, Yingmei Wang, Xishan Hao, Qingyi Wei, Wei Zhang, and Kexin Chen. Definition of a functional single nucleotide polymorphism in the cell migration inhibitory gene miip that affects the risk of breast cancer. Cancer Research, 70(3):1024–1032, January 2010. URL: http://dx.doi.org/10.1158/0008-5472.can-09-3742, doi:10.1158/0008-5472.can-09-3742. This article has 14 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-09-3742)

[5. (Chen2017PKCε) Tao Chen, Jingjie Li, Meidong Xu, Qin Zhao, Yingyong Hou, Liqing Yao, Yunshi Zhong, Ping-Chieh Chou, Wei Zhang, Pinghong Zhou, and Yuhui Jiang. Pkcε phosphorylates miip and promotes colorectal cancer metastasis through inhibition of rela deacetylation. Nature Communications, October 2017. URL: http://dx.doi.org/10.1038/s41467-017-01024-2, doi:10.1038/s41467-017-01024-2. This article has 32 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-017-01024-2)

[6. (Wang2016MIIP) Yingmei Wang, Limei Hu, Ping Ji, Fei Teng, Wenyan Tian, Yuexin Liu, David Cogdell, Jinsong Liu, Anil K. Sood, Russell Broaddus, Fengxia Xue, and Wei Zhang. Miip remodels rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis. Journal of Hematology &amp; Oncology, October 2016. URL: http://dx.doi.org/10.1186/s13045-016-0342-6, doi:10.1186/s13045-016-0342-6. This article has 16 citations.](https://doi.org/10.1186/s13045-016-0342-6)

[7. (Yan2019MIIP) Guang Yan, Yi Ru, Fengqi Yan, Xin Xiong, Wei Hu, Tao Pan, Jianming Sun, Chi Zhang, Qinhao Wang, and Xia Li. Miip inhibits the growth of prostate cancer via interaction with pp1α and negative modulation of akt signaling. Cell Communication and Signaling, May 2019. URL: http://dx.doi.org/10.1186/s12964-019-0355-1, doi:10.1186/s12964-019-0355-1. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-019-0355-1)